Carbetocin Versus Oxytocin in the Prevention of Post Partum Haemorrhage (PPH) in Women Undergoing Caesarean Sections for Placenta Previa: A Randomised Controlled Trial
Post Partum Haemorrhage
About this trial
This is an interventional prevention trial for Post Partum Haemorrhage focused on measuring Obstetrics
Eligibility Criteria
Inclusion Criteria:
- Women undergoing CS for placenta previa
Exclusion Criteria:
- Gestational age <37 weeks
- Hypertension
- Preeclampsia
- Cardiac, renal or liver diseases
- Need for general anaesthesia
- Known hypersensitivity to carbetocin
- Suspected placenta accreta
Sites / Locations
- BeniSuef University hospitalsRecruiting
- Cairo university hospitalsRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Carbetocin
Oxytocin
100 µgm of Carbetocin will be diluted in 10ml saline and will be given by the anesthesist slowly intravenously after delivery of the baby. The uterine tone and amount of bleeding will be noted and the need for further uterotonic agents will be determined 2 minutes after giving the drug.
5 mg of oxytocin will be diluted in 10ml saline and will be given by the anesthesist slowly intravenously after delivery of the baby. The uterine tone and amount of bleeding will be noted and the need for further uterotonic agents will be determined 2 minutes after giving the drug.